A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

As a result of the acquisition, NAMSA assumes the U.S. portfolio of services of Labcorp’s Early Development medical device ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry ...

Labcorp is a global leader of innovative and comprehensive laboratory services. The company's Venture Fund invests in and supports early stage, private companies that are focused on improving health ...

PracticeQ and Fullscript partner to simplify lab ordering and results management, helping providers deliver faster, more connected care.

LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and strategic ...

Company expands its ecosystem of investors with new financing from InHealth Ventures, part of a large UK-based health system, and the Labcorp Venture Fund IMVARIA Inc., a health tech company pioneerin ...